Vargas PN, Lawson CA, Harter S, Bolaños BG

Language: Spanish
References: 10
Page: 373-376
PDF size: 196.98 Kb.

ABSTRACT

In recent decades, a significant increase in the incidence of testicular tumors has been reported. Such tumors are also the most common malignancy men age 20-34 years old. About 95% are tumors derived from germ cells (50% are seminoma and 50% non-seminoma) and only 5% are tumors derived from germ cells.

REFERENCES

1. Albers, P et al. (2012). Guía clínica sobre el cáncer de testículo de la EAU: actualización de 2011. Editorial Elsevier Doyma. España.

2. Feldman, D. (2014) Medical Treatment of Advanced Testicular Cáncer. JAMA.

3. Hege, S. (2012) Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up.

4. Huyghe, E et Al. (2003). Increasing incidence of testicular cancer world.

5. Jaramillo, J et al. (1991).El Cáncer. Fundamentos de Oncología, Editorial Universidad de Costa Rica. Costa Rica.

6. Leendert H. et al (2014). Testicular cancer: biology and biomarkers. Virchows Arch

7. Liannoy et al (2013). Caracterización de los tumores testiculares de células germinales según biopsias del servicio de patología. Hospital México, Costa Rica: enero 2003 a marzo 2011. Acta Médica Costarricense.

8. Lydia Ferguson et al. (2013). Testicular cancer and cryptorchidism. Frontiers in endocrinology.

9. R de Wit1 et al. (1998). Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC.

10. www. cancer. gov/espanol/pdq/tratamiento/testiculo/HealthProfessional/page7. Última revisión 09/11/14 a las 9:05pm.